Make Informed Investment Decisions with Affordable Access to Experts
Freedom of Information Act Request
Linzess FAERS database request in light of the Phase V Research report released on 4/26/16 highlighting deathsTicker(s): IRWD, AGN, SGYP
The Phase V Research report focused on a number of reasons the authors thought Ironwood was a short, but the results of a FEARS request on Linzess was a central point. On the morning of 4/27/16 some commenters on Twitter thought the FEARS exhibits had been changed. Based on this debate a most likely very cheap and fast request from the agency and posted to this project page will be confirmatory.
A call discussing the FAERS cases with a GI expert is also proposed on Slingshot Insights. Some of the causes for death sound less drug related and more related to the underlying issue of constipation. (Fecal vomiting).
Government Agency: FDA
Specific Documents Requested: FAERS database for the drug Linzess (linaclotide) since the drug has been on the market
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.